These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25824637)

  • 1. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Hoefnagels WH; Beekman AT; de Groot LC
    Am J Clin Nutr; 2008 Sep; 88(3):706-13. PubMed ID: 18779287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
    McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
    [No Abstract]   [Full Text] [Related]  

  • 4. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
    Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
    Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
    Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
    Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
    Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study.
    De Truchis P; Kirstetter M; Perier A; Meunier C; Zucman D; Force G; Doll J; Katlama C; Rozenbaum W; Masson H; Gardette J; Melchior JC
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):278-85. PubMed ID: 17179770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
    Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
    Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial.
    Bo Y; Zhang X; Wang Y; You J; Cui H; Zhu Y; Pang W; Liu W; Jiang Y; Lu Q
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28075381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers.
    Buydens-Branchey L; Branchey M; Hibbeln JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):568-75. PubMed ID: 18060675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.
    Chhetry BT; Hezghia A; Miller JM; Lee S; Rubin-Falcone H; Cooper TB; Oquendo MA; Mann JJ; Sublette ME
    J Psychiatr Res; 2016 Apr; 75():65-74. PubMed ID: 26802812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
    Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
    BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.
    Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC
    J Nutr Biochem; 2013 Jul; 24(7):1367-72. PubMed ID: 23333088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.
    Amminger GP; Chanen AM; Ohmann S; Klier CM; Mossaheb N; Bechdolf A; Nelson B; Thompson A; McGorry PD; Yung AR; Schäfer MR
    Can J Psychiatry; 2013 Jul; 58(7):402-8. PubMed ID: 23870722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.